Home > News & Activities > Latest News

Latest News

Not Guilty: Living with HIV and the law

This NAPWHA breakfast discussion at the 2019 Australasian HIV&AIDS Conference in Perth provides an opportunity for multi-disciplinary delegates to hear and gain insight and current information from leaders in the field working in the field of HIV criminalisation in Australia and the region.

Heads together: We can transform the region

This NAPWHA evening at the 2019 Australasian HIV&AIDS Conference in Perth discussion will bring together experts including community representatives, clinicians and researchers who are involved in the HIV response in these Papua New Guinea (PNG) and Timor Leste to identify current problems and issues and to investigate solutions.

Pharmaceutical Benefits Scheme to delist Stribild® and Evipera® from 1 March 2020

NAPWHA wish to update our HIV community/ies and organisational members that from 1 March 2020 the Single Tablet Regimen (STR) HIV treatments Eviplera ® (tenofovir disoproxil fumarate, emtricitabine and rilpivirine) and Stribild ® (cobicistat, elvitegravir, emtricitabine and tenofovir disoproxil fumarate) will no longer be available via the Australian Pharmaceutical Benefits Scheme (PBS).

Nominations for the Board of Directors now open

Nominations for the NAPWHA Board of Directors is now open until Monday 23 September 2019. This is a fantastic opportunity for inspirational leaders who have a genuine passion for advancing the rights of people living with HIV.

Share This